-
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary SyndromeG Tarantini , M Mojoli , F Varbella et al. -
MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) SubstudyFalkentoft AC, Rørth R, Iversen K et al.
-
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study GroupV Kunadian, A Chieffo, PG Camici et al.
-
Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK TrialP Guedeney, O Barthélémy, M Zeitouni et al. cardiogenic shockpercutaneous coronary interventionSYNTAX score
-
Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort studyDS Yuan, Z Gao, JQ Yuan et al.
-
Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic ShockSS Dhruva, JS Ross, BJ Mortazavi et al.
-
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial InfarctionB Levy, R Clere-Jehl, A Legras et al.
-
Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary SyndromeS Stojkovic, PP Wadowski, P Haider et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
